Cargando…
DNA methylation-mediated Klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma
PURPOSE: To study the prognostic value of klotho (KL) and its promoter DNA methylation in head and neck squamous cell carcinoma (HNSCC) and to assess their associations with the autophagy gene LC3 and the RNA transferase gene NSUN2. MATERIALS AND METHODS: Upper quartile normalized RNA-seq V2 RSEM va...
Autores principales: | Zhu, Yun, Cao, Xuehong, Zhang, Xiaomeng, Chen, Quan, Wen, Lei, Wang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388988/ https://www.ncbi.nlm.nih.gov/pubmed/30863149 http://dx.doi.org/10.2147/CMAR.S188415 |
Ejemplares similares
-
DNA Methylation Induced Epigenetic Silencing: A Potential Biomarker and Therapeutic Target for Head and Neck Squamous Cell Carcinoma
por: Patil, Shankargouda, et al.
Publicado: (2015) -
Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation
por: Feng, Yao, et al.
Publicado: (2023) -
Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017) -
Salivary-Based Cell-Free Mitochondrial DNA Level Is an Independent Prognostic Biomarker for Patients with Head and Neck Squamous Cell Carcinoma
por: Sayal, Lana, et al.
Publicado: (2023) -
ATHENA: an independently validated autophagy-related epigenetic prognostic prediction model of head and neck squamous cell carcinoma
por: Xu, Ziang, et al.
Publicado: (2023)